| Jan 2, 2026 |
Jan 5, 2026 |
Fortress Biotech, Inc.
|
10% Owner |
Neutral |
90.0
|
+278,385
|
107.82%
|
✗
|
- |
| Dec 30, 2025 |
Dec 30, 2025 |
Herskowitz Neil
|
Director |
Sell |
27.5
|
-247
|
-63.01%
|
✗
|
$237.6 |
| Dec 30, 2025 |
Dec 30, 2025 |
Chill Adam J.
|
Director |
Sell |
27.5
|
-4
|
-1.06%
|
✗
|
$3.8 |
| Dec 30, 2025 |
Dec 30, 2025 |
Jin David
|
Director |
Buy |
90.0
|
+247
|
633.33%
|
✗
|
$237.6 |
| Sep 29, 2025 |
Oct 1, 2025 |
Fortress Biotech, Inc.
|
10% Owner |
Neutral |
90.0
|
+59,334
|
29.84%
|
✗
|
- |
| Apr 24, 2025 |
Apr 28, 2025 |
Litchman Manuel MD
|
CEO |
Sell |
27.5
|
-27
|
-1.63%
|
✗
|
$33.5 |
| Mar 31, 2025 |
Apr 2, 2025 |
Fortress Biotech, Inc.
|
10% Owner |
Neutral |
90.0
|
+67,806
|
51.74%
|
✗
|
- |
|
Jan 3, 2025 |
Fortress Biotech, Inc.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Oct 29, 2024 |
Jin David
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 31, 2024 |
Jun 4, 2024 |
Litchman Manuel MD
|
CEO |
Sell |
27.5
|
-1,396
|
-1.65%
|
✗
|
$488.6 |
| Apr 24, 2022 |
Jun 4, 2024 |
Litchman Manuel MD
|
CEO |
Sell |
26.3
|
-2,820
|
-3.43%
|
✗
|
$21.8K |
|
Feb 12, 2024 |
MURPHY JAMES B
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 19, 2023 |
Carney Peter
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 5, 2023 |
Jul 7, 2023 |
ZELEFSKY MICHAEL J
|
Director |
Neutral |
90.0
|
+7,246
|
61.80%
|
✗
|
- |
| Jul 5, 2023 |
Jul 7, 2023 |
Chill Adam J.
|
Director |
Neutral |
90.0
|
+7,246
|
60.77%
|
✗
|
- |
| Jul 5, 2023 |
Jul 7, 2023 |
ROSENWALD LINDSAY A MD
|
Director |
Neutral |
90.0
|
+7,246
|
13.60%
|
✗
|
- |
| Jul 5, 2023 |
Jul 7, 2023 |
WEISS MICHAEL S
|
Director |
Neutral |
90.0
|
+7,246
|
17.09%
|
✗
|
- |
| Jul 5, 2023 |
Jul 7, 2023 |
Herskowitz Neil
|
Director |
Neutral |
90.0
|
+7,246
|
58.17%
|
✗
|
- |
| Apr 24, 2023 |
Jul 7, 2023 |
Litchman Manuel MD
|
CEO |
Neutral |
82.5
|
+5,000
|
4.71%
|
✗
|
- |
|
Apr 6, 2023 |
WEISS MICHAEL S
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 6, 2023 |
ROSENWALD LINDSAY A MD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 18, 2022 |
Apr 3, 2023 |
Litchman Manuel MD
|
Director |
Buy |
85.0
|
+71,000
|
6.91%
|
✗
|
$6.3K |
| Mar 18, 2022 |
Apr 3, 2023 |
ROSENWALD LINDSAY A MD
|
Director |
Buy |
90.0
|
+80,758
|
36.97%
|
✗
|
$5.6K |
| Jul 29, 2022 |
Apr 3, 2023 |
Herskowitz Neil
|
Director |
Neutral |
90.0
|
+71,664
|
62.21%
|
✗
|
- |
| Jul 29, 2022 |
Apr 3, 2023 |
ZELEFSKY MICHAEL J
|
Director |
Neutral |
90.0
|
+71,664
|
68.78%
|
✗
|
- |
| Jul 29, 2022 |
Apr 3, 2023 |
Chill Adam J.
|
Director |
Neutral |
90.0
|
+71,664
|
66.85%
|
✗
|
- |
| Jul 29, 2022 |
Apr 3, 2023 |
WEISS MICHAEL S
|
Director |
Neutral |
90.0
|
+71,664
|
111.63%
|
✗
|
- |
|
Jun 7, 2022 |
Lurier Eliot M
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 8, 2021 |
Dec 16, 2021 |
Achenbach Brian
|
SVP, Fin. & Corp. Controller |
Sell |
90.0
|
+18,126
|
14.32%
|
✗
|
$8K |
| Oct 27, 2021 |
Nov 8, 2021 |
Litchman Manuel MD
|
CEO |
Buy |
90.0
|
+65,000
|
6.75%
|
✗
|
$145.6K |
| Oct 12, 2021 |
Oct 21, 2021 |
Achenbach Brian
|
SVP, Fin. & Corp. Controller |
Sell |
46.3
|
-4,450
|
-3.40%
|
✗
|
$10.1K |
| Aug 31, 2021 |
Sep 24, 2021 |
ROSENWALD LINDSAY A MD
|
Director |
Neutral |
67.5
|
+1,170
|
0.54%
|
✗
|
- |
| Aug 31, 2021 |
Sep 24, 2021 |
Litchman Manuel MD
|
CEO |
Neutral |
60.0
|
+2,746
|
0.29%
|
✗
|
- |
| Jul 30, 2021 |
Aug 5, 2021 |
Litchman Manuel MD
|
CEO |
Buy |
92.5
|
+86,206
|
9.86%
|
✗
|
$250.9K |
| Jun 28, 2021 |
Jul 8, 2021 |
ZELEFSKY MICHAEL J
|
Director |
Neutral |
90.0
|
+13,774
|
15.23%
|
✗
|
- |
| Jun 28, 2021 |
Jul 8, 2021 |
WEISS MICHAEL S
|
Director |
Neutral |
90.0
|
+13,774
|
27.32%
|
✗
|
- |
| Jun 28, 2021 |
Jul 8, 2021 |
ROSENWALD LINDSAY A MD
|
Director |
Neutral |
85.0
|
+13,774
|
6.77%
|
✗
|
- |
| Jun 17, 2021 |
Jul 8, 2021 |
Litchman Manuel MD
|
CEO |
Neutral |
85.0
|
+61,000
|
7.50%
|
✗
|
- |
| Jun 28, 2021 |
Jul 8, 2021 |
Herskowitz Neil
|
Director |
Neutral |
90.0
|
+13,774
|
13.58%
|
✗
|
- |
| Jun 28, 2021 |
Jul 8, 2021 |
Chill Adam J.
|
Director |
Neutral |
90.0
|
+13,774
|
14.74%
|
✗
|
- |
| May 22, 2020 |
Apr 29, 2021 |
Litchman Manuel MD
|
CEO |
Sell |
46.3
|
-12,373
|
-1.50%
|
✗
|
$37.6K |
| Dec 6, 2019 |
Apr 16, 2021 |
Achenbach Brian
|
SVP, Fin. & Corp. Controller |
Sell |
42.5
|
-20,721
|
-13.65%
|
✗
|
$66.3K |
| Feb 26, 2021 |
Mar 15, 2021 |
Litchman Manuel MD
|
CEO |
Buy |
97.5
|
+170,562
|
26.05%
|
✗
|
$516.6K |
| Feb 26, 2021 |
Mar 15, 2021 |
ROSENWALD LINDSAY A MD
|
Director |
Neutral |
67.5
|
+1,043
|
0.52%
|
✗
|
- |
| Dec 15, 2020 |
Mar 15, 2021 |
Achenbach Brian
|
SVP, Fin. & Corp. Controller |
Neutral |
90.0
|
+22,500
|
17.40%
|
✗
|
- |
| Aug 31, 2020 |
Dec 22, 2020 |
ROSENWALD LINDSAY A MD
|
Director |
Buy |
97.5
|
+101,182
|
99.93%
|
✗
|
$266K |
| Feb 28, 2020 |
Dec 22, 2020 |
ROSENWALD LINDSAY A MD
|
Director |
Neutral |
90.0
|
+17,442
|
20.81%
|
✗
|
- |
| Aug 31, 2020 |
Dec 22, 2020 |
Litchman Manuel MD
|
CEO |
Buy |
97.5
|
+166,000
|
33.96%
|
✗
|
$291K |
| Dec 14, 2020 |
Dec 15, 2020 |
ROSENWALD LINDSAY A MD
|
Director |
Buy |
97.5
|
+100,000
|
99.58%
|
✗
|
$266K |
| Jul 14, 2020 |
Aug 19, 2020 |
ZELEFSKY MICHAEL J
|
Director |
Neutral |
90.0
|
+16,611
|
22.50%
|
✗
|
- |
| Jul 14, 2020 |
Aug 19, 2020 |
WEISS MICHAEL S
|
Director |
Neutral |
90.0
|
+16,611
|
49.13%
|
✗
|
- |
| Jul 14, 2020 |
Aug 19, 2020 |
ROSENWALD LINDSAY A MD
|
Director |
Neutral |
90.0
|
+16,611
|
19.82%
|
✗
|
- |
| Jul 14, 2020 |
Aug 19, 2020 |
Herskowitz Neil
|
Director |
Neutral |
90.0
|
+16,611
|
19.59%
|
✗
|
- |
| Jul 14, 2020 |
Aug 19, 2020 |
Chill Adam J.
|
Director |
Neutral |
90.0
|
+16,611
|
21.63%
|
✗
|
- |
| Jun 11, 2020 |
Jun 15, 2020 |
Litchman Manuel MD
|
CEO |
Buy |
97.5
|
+153,846
|
45.92%
|
✗
|
$500K |
| May 14, 2020 |
May 22, 2020 |
Litchman Manuel MD
|
CEO |
Buy |
97.5
|
+180,000
|
116.13%
|
✗
|
$532.8K |
| Mar 5, 2020 |
Apr 29, 2020 |
Litchman Manuel MD
|
CEO |
Neutral |
90.0
|
+127,000
|
453.57%
|
✗
|
- |
| Mar 5, 2020 |
Apr 29, 2020 |
Achenbach Brian
|
SVP, Fin. & Corp. Controller |
Neutral |
90.0
|
+36,774
|
39.76%
|
✗
|
- |
|
Apr 29, 2020 |
ZELEFSKY MICHAEL J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 16, 2019 |
Jan 17, 2020 |
Achenbach Brian
|
SVP, Fin. & Corp. Controller |
Neutral |
90.0
|
+35,000
|
60.87%
|
✗
|
- |
| Aug 28, 2019 |
Jan 17, 2020 |
Herskowitz Neil
|
Director |
Neutral |
90.0
|
+13,812
|
19.45%
|
✗
|
- |
| Aug 28, 2019 |
Jan 17, 2020 |
Chill Adam J.
|
Director |
Neutral |
90.0
|
+13,812
|
21.92%
|
✗
|
- |
| Jun 14, 2018 |
Jan 17, 2020 |
WEISS MICHAEL S
|
Director |
Neutral |
90.0
|
+23,812
|
238.12%
|
✗
|
- |
| Aug 28, 2019 |
Jan 17, 2020 |
ROSENWALD LINDSAY A MD
|
Director |
Neutral |
90.0
|
+13,812
|
19.73%
|
✗
|
- |
| Jun 14, 2018 |
Jan 17, 2020 |
ROSENWALD LINDSAY A MD
|
Director |
Neutral |
90.0
|
+10,000
|
100.00%
|
✗
|
- |
| Nov 20, 2018 |
Dec 18, 2018 |
Litchman Manuel MD
|
CEO |
Buy |
95.0
|
+28,000
|
100.00%
|
✗
|
$103.9K |
| Jun 14, 2018 |
Dec 7, 2018 |
Herskowitz Neil
|
Director |
Buy |
90.0
|
+11,000
|
18.33%
|
✗
|
$4K |
| Feb 2, 2018 |
Dec 3, 2018 |
Achenbach Brian
|
VP, Fin. & Corp. Controller |
Buy |
91.3
|
+57,500
|
100.00%
|
✗
|
$10.5K |
|
Nov 27, 2018 |
Achenbach Brian
|
VP, Fin. & Corp. Controller |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 14, 2018 |
Nov 13, 2018 |
Chill Adam J.
|
Director |
Neutral |
90.0
|
+13,000
|
26.00%
|
✗
|
- |
| Nov 2, 2018 |
Nov 5, 2018 |
ROSENWALD LINDSAY A MD
|
Director |
Buy |
95.0
|
+50,000
|
250.00%
|
✗
|
$220.5K |
|
Jul 20, 2017 |
WEISS MICHAEL S
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 20, 2017 |
Chill Adam J.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 20, 2017 |
ROSENWALD LINDSAY A MD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 30, 2017 |
WEISS MICHAEL S
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 30, 2017 |
Litchman Manuel MD
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 30, 2017 |
Horin David J
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 30, 2017 |
Chill Adam J.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 30, 2017 |
Herskowitz Neil
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |